314 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
SE | US$94.31 | 10.0% | 114.6% | US$54.5b | US$86.20 | PS3.7x | E49.4% | n/a | Media | ||
4755 | JP¥965.70 | -0.5% | 57.5% | JP¥2.1t | JP¥953.53 | PB2.4x | E81.9% | 0% | Retail | ||
CYBR | US$282.89 | 0.8% | 72.7% | US$12.4b | US$307.70 | PS14.2x | E42.5% | n/a | Software | ||
UCB | €161.35 | -0.8% | 108.1% | €30.6b | €165.00 | PE127.5x | E35.6% | 0.8% | Pharmaceuticals & Biotech | ||
DKNG | US$40.36 | 2.7% | 37.1% | US$19.9b | US$49.52 | PS4.6x | E61.6% | n/a | Consumer Services | ||
6502 | JP¥4,590.00 | 0% | 5.2% | JP¥2.0t | JP¥4,606.67 | PB1.6x | E81.9% | 0% | Capital Goods | ||
KRTX | US$329.83 | 3.3% | 80.7% | US$12.6b | US$326.92 | PS19238.9x | E60.1% | n/a | Pharmaceuticals & Biotech | ||
BGNE | US$218.42 | 8.1% | 21.4% | US$22.6b | US$274.14 | PS7.5x | E64.1% | n/a | Pharmaceuticals & Biotech | ||
TFX | US$246.83 | 1.8% | 25.7% | US$11.5b | US$258.65 | PE43.9x | E21.3% | 0.6% | Healthcare | ||
2802 | JP¥5,722.00 | 5.1% | -0.7% | JP¥2.9t | JP¥6,505.83 | PE34.5x | E12.7% | 0.7% | Food, Beverage & Tobacco | ||
3908 | HK$12.52 | 50.1% | -12.8% | HK$137.7b | HK$12.41 | PE13.1x | E22.2% | 1.6% | Diversified Financials | ||
GFL | CA$53.12 | -0.3% | 23.2% | CA$20.9b | CA$57.05 | PS2.7x | E115.1% | 0.1% | Commercial Services | ||
2230 | CN¥40.40 | 16.5% | -20.3% | CN¥92.6b | CN¥46.70 | PE506x | E60.0% | 0.2% | Software | ||
NTRA | US$125.72 | -1.6% | 184.1% | US$15.3b | US$130.17 | PS11.4x | E70.5% | n/a | Pharmaceuticals & Biotech | ||
ENR | €32.90 | 1.9% | 165.8% | €25.7b | €29.76 | PE44.6x | E21.1% | 0% | Capital Goods | ||
S32 | AU$3.70 | 15.6% | 9.1% | AU$16.7b | AU$3.59 | PS2.1x | E46.0% | 0.2% | Materials | ||
FWON.K | US$78.15 | 0.5% | 25.4% | US$18.2b | US$91.20 | PE66.2x | E25.6% | n/a | Media | ||
MTX | €281.10 | 0.9% | 63.7% | €15.1b | €273.25 | PS2.7x | E35.2% | 0.7% | Capital Goods | ||
HZNP | US$116.30 | 0.06% | 82.8% | US$26.6b | US$116.50 | PE60.8x | E16.4% | n/a | Pharmaceuticals & Biotech | ||
EXAS | US$65.96 | -5.9% | -3.3% | US$12.6b | US$77.57 | PS4.7x | E70.9% | n/a | Pharmaceuticals & Biotech | ||
300498 | CN¥18.32 | 16.6% | 5.4% | CN¥121.9b | CN¥20.39 | PS1.3x | E57.7% | 0.5% | Food, Beverage & Tobacco | ||
PUREHEALTH | د.إ3.58 | -2.2% | n/a | د.إ39.8b | د.إ6.08 | PE64.5x | E29.7% | n/a | Healthcare | ||
RDDT | US$67.08 | 1.4% | n/a | US$11.0b | US$67.50 | PS11.3x | E82.7% | n/a | Media | ||
DSY | €36.65 | 1.8% | 3.8% | €48.2b | €38.94 | PE42.9x | E13.8% | 0.6% | Software |